Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
Vietnam
· Delayed Price · Currency is VND 24,800
0.00 (0.00%)
At close: Mar 9, 2026
HNX:MKV Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | 16,901 | 7,324 | 6,201 | 5,904 | 1,767 | Upgrade
|
| Depreciation & Amortization | 4,178 | 4,231 | 7,171 | 7,816 | 8,546 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -467.33 | -196.35 | 17,853 | Upgrade
|
| Other Operating Activities | -317.9 | -1,987 | 145.11 | -213.68 | -7,875 | Upgrade
|
| Change in Accounts Receivable | 2,579 | -5,557 | -8,042 | -3,844 | 10,585 | Upgrade
|
| Change in Inventory | -1,562 | -3,652 | 15,683 | 450.63 | 3,945 | Upgrade
|
| Change in Accounts Payable | -9,951 | 4,842 | 4,650 | -2,471 | -13,298 | Upgrade
|
| Change in Other Net Operating Assets | 101.34 | 395.47 | 49.34 | 145.92 | 384.62 | Upgrade
|
| Operating Cash Flow | 11,927 | 5,597 | 25,391 | 7,592 | 21,909 | Upgrade
|
| Operating Cash Flow Growth | 113.10% | -77.96% | 234.43% | -65.35% | 110.46% | Upgrade
|
| Capital Expenditures | -1,354 | - | -984.46 | -561.05 | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 181.82 | - | - | Upgrade
|
| Other Investing Activities | 668.95 | 386.42 | 330.98 | 178.8 | 1.04 | Upgrade
|
| Investing Cash Flow | -23,685 | 386.42 | -471.66 | -382.25 | 1.04 | Upgrade
|
| Short-Term Debt Issued | - | 5,010 | 9,087 | 50,133 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 64,019 | Upgrade
|
| Total Debt Issued | - | 5,010 | 9,087 | 50,133 | 64,019 | Upgrade
|
| Short-Term Debt Repaid | - | -5,010 | -27,492 | -56,235 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -85,126 | Upgrade
|
| Total Debt Repaid | - | -5,010 | -27,492 | -56,235 | -85,126 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -18,405 | -6,102 | -21,107 | Upgrade
|
| Common Dividends Paid | - | - | -1,500 | - | - | Upgrade
|
| Financing Cash Flow | - | - | -19,905 | -6,102 | -21,107 | Upgrade
|
| Net Cash Flow | -11,758 | 5,983 | 5,014 | 1,108 | 802.87 | Upgrade
|
| Free Cash Flow | 10,573 | 5,597 | 24,406 | 7,031 | 21,909 | Upgrade
|
| Free Cash Flow Growth | 88.92% | -77.07% | 247.11% | -67.91% | 193.49% | Upgrade
|
| Free Cash Flow Margin | 7.10% | 5.23% | 22.01% | 5.88% | 21.39% | Upgrade
|
| Free Cash Flow Per Share | 2114.58 | 1119.37 | 4881.24 | 1406.48 | - | Upgrade
|
| Cash Interest Paid | - | 38.53 | 577.22 | 1,157 | 3,830 | Upgrade
|
| Cash Income Tax Paid | 3,867 | 3,431 | 1,300 | 1,475 | 1,040 | Upgrade
|
| Levered Free Cash Flow | 6,457 | 6,521 | 26,537 | - | 14,676 | Upgrade
|
| Unlevered Free Cash Flow | 9,024 | 6,546 | 26,838 | - | 17,108 | Upgrade
|
| Change in Working Capital | -8,834 | -3,971 | 12,341 | -5,718 | 1,617 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.